Clinical trial • No longer enrolling • 14 March 2011
A Randomized, Double-Blind Study of the Safety and Efficacy of GSK1349572 Plus Abacavir/Lamivudine Fixed-Dose Combination Therapy Administered Once Daily Compared to Atripla Over 96 Weeks in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Clinical trial • Concluded • 24 March 2009
A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1
Tags: drug resistance, NNRTI
Clinical trial • Reported • 11 May 2007
A Randomised Open-Label Study Comparing the Safety and Efficacy of Three Different Combination Antiretroviral Regimens as Initial Therapy for HIV Infection
Tags: first-line therapy, starting treatments
Clinical trial • Fully enrolled • 24 January 2012
Non-nucleoside Reverse Transcriptase Inhibitor Failure in a High HIV Caseload Australian Primary Care Practice
Clinical trial • Reported • 16 January 2012
An Investigational Vaccine in Reducing the Incidence of Anogenital Warts in Young Men
Tags: anal cancer, HPV
Clinical trial • Concluded • 21 August 2009
A Randomised, Open-Label, Cross-Over Study to Examine the Pharmacokinetics and Short-Term Safety and Efficacy of Two Dosing Strategies of Raltegravir Plus Atazanavir in HIV-Infected Patients
Tags: atazanavir, first-line therapy, raltegravir
Clinical trial • No longer enrolling • 3 November 2010
A Randomized, Double Blind Study of the Safety and Efficacy of GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily Both Administered With Fixed-dose Dual Nucleoside Reverse Transcriptase Inhibitor Therapy Over 96 Weeks in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
Clinical trial • Reported • 10 May 2007
An Open-Label Trial with TMC125 in Patients Who Have Virologically Failed in a DUET Trial (TMC125-C206 or TMC125-C216)
Clinical trial • No longer enrolling • 22 October 2008
Impact of HIV Infection and Treatment With Highly Active Antiretroviral Therapy on Reverse Cholesterol Transport
Tags: heart disease
Clinical trial • Fully enrolled • 11 April 2008
The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection (PINT)
Clinical trial • Fully enrolled • 24 March 2011
Do homosexual men test more frequently for human immunodeficiency virus (HIV) with rapid tests? A randomised controlled trial.
Clinical trial • No longer enrolling • 3 August 2010
Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults
Clinical trial • No longer enrolling • 21 May 2010
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults
Clinical trial • Fully enrolled • 28 March 2008
A Randomised, Double Blind, Double Dummy, Parallel Group, Active Controlled Trial to Evaluate the Antiviral Efficacy of 400 mg QD Nevirapine Extended Release Formulation in Comparison to 200 mg BID Nevirapine Immediate Release in Combination With Truvada? in Antiretroviral Therapy Naive HIV-1 Infect
Tags: liver disorders, optimised background regimens, treatment side effects
Clinical trial • Concluded • 22 October 2008
A Phase III, Randomized, Double-Blind Trial of TMC278 25mg q.d. Versus Efavirenz 600mg q.d. in Combination With a Background Regimen Containing 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Naive HIV-1 Infected Subjects >>>>> AND <<<< A Phase III, Randomized, Double-Blind Trial of TMC278 25 mg q.d. Versus Efavirenz 600mg q.d. in Combination With a Fixed Background Regimen Consisting of Tenofovir Disoproxil Fumarate and Emtricitabine in Antiretroviral-Naive HIV-1 Infected Subjects.
Clinical trial • No longer enrolling • 22 October 2008
A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL) Each Administered With a Background Regimen in HIV-1 Infected, Antiretroviral Treatment-Experienced Adults
Tags: Elvitegravir, integrase inhibitor, raltegravir
Clinical trial • Concluded • 8 April 2009
A one-year, open label, extension study of flupirtine for the treatment of painful HIV-sensory neuropathy in patients who have pain inadequately controlled by opioids
Tags: peripheral neuropathy
Clinical trial • Unknown • 19 February 2010
Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History
Tags: hepatitis B
Clinical trial • Concluded • 17 February 2010
A Phase II, Randomised, Double-blind, Dose-ranging Study of AVX754 Versus Lamivudine in Treatment-experienced HIV-1 Infected Patients With the M184V Mutation in Reverse Transcriptase
Tags: drug resistance, NRTI
Clinical trial • Cancelled • 10 May 2007
A multicentre, Double-Blind, Randomised, Placebo-Controlled Phase II Proof-of-Concept Study to Evaluate the Safety and Efficacy of a 3-Dose Regimen of the Merck Adenovirus Serotype-5 HIV-1 Vaccine gag/pol/nef (MRKad5 HIV-1 gag/pol/nef in Adults at High Risk of HIV-1 Infection
Tags: preventative vaccines, Safe sex
This site complies with the HONcode standard for trustworthy health information: verify here. 